Breast Imaging Devices Global Market Report 2021: COVID-19 Impacts, Growth and Changes to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Breast Imaging Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global breast imaging devices market is expected to grow from $3.461 billion in 2020 to $3.754 billion in 2021 at a compound annual growth rate (CAGR) of 8.5%.

Major players in the breast imaging devices market are Siemens Healthcare, GE Healthcare, Dilon Technologies Inc., Hologic, Inc., Gamma Medica Inc., Fujifilm Holdings Corporation, SonoCine Inc, Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology Inc.

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.091 billion in 2025 at a CAGR of 13%.

The breast imaging devices market consists of sales of breast imaging devices and related services by entities (organizations, sole traders, and partnerships) that manufacture breast imaging devices. Breast imaging devices are medical devices used in the diagnosis of medical conditions related to the breast. Some of the breast imaging processes include mammography, MRI, and ultrasound.

Major players operating in breast imaging devices market are undertaking various strategic initiatives such as the launch of technologically advanced or innovative products and product portfolio expansion, which is likely to be a leading trend in the breast imaging market. Various companies are introducing new advanced devices in the market to attract a large customer base and maintain their position in the competitive business environment.

The breast imaging devices market covered in this report is segmented by product type into tomosynthesis; breast ultrasound; breast MRI; mammography; nuclear imaging; others. It is also segmented by technology into ionizing; non ionizing, and by end user into hospitals and clinics; breast care centers; diagnostic imaging centers.

In June 2019, Hologic, Inc., a USA-based innovative medical technology company focused on improving women's health and well-being through early treatment and diagnosis, announced the acquisition of SuperSonic Imagine for an amount of $85 million. With the acquisition of SuperSonic Imagine, Hologic, Inc. aims to gain entry in cart-based breast ultrasound technology used to screen women with dense breast tissue. SuperSonic Imagine is a France-based company specialized in ultrasound medical imaging including breast imaging devices.

The rising prevalence of breast cancer is anticipated to contribute to the breast imaging devices market's growth. A growing number of hormone replacement therapy (HRT), hormonal imbalances, menopause, and various reproductive disorders have significantly increased the risks of breast cancer. According to the World Health Organization (WHO), breast cancer is the most common cancer in women, impacting 2.1 million women annually.

High cost associated with breast imaging devices is expected to limit the growth of the market in the near future. The cost of digital mammography systems varies for different models and companies. For instance, the cost of the 2D model's mammography systems ranges between $65,000 to $95,000 for GE Healthcare and Hologic, Inc products.

Whereas 3D models of the same company's range between $90,000 to $200,000. In addition to this, the premium 3D models of GE Healthcare and Hologic Inc. are priced between $1,40,000 to $2,75,000. Therefore, the high cost of breast imaging systems is a major concern for end-users, which is predicted to hinder the growth of breast imaging devices market over the forecast period.

Key Topics Covered:

1. Executive Summary

2. Breast Imaging Devices Market Characteristics

3. Breast Imaging Devices Market Trends and Strategies

4. Impact of COVID-19 on Breast Imaging Devices

5. Breast Imaging Devices Market Size and Growth

5.1. Global Breast Imaging Devices Historic Market, 2015-2020, $ Billion

5.1.1. Drivers of the Market

5.1.2. Restraints on The Market

5.2. Global Breast Imaging Devices Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers of the Market

5.2.2. Restraints on the Market

6. Breast Imaging Devices Market Segmentation

6.1. Global Breast Imaging Devices Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Tomosynthesis
• Breast Ultrasound
• Breast MRI
• Mammography
• Nuclear Imaging
• Others

6.2. Global Breast Imaging Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Ionizing
• Non Ionizing

6.3. Global Breast Imaging Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Hospitals & Clinics
• Breast Care Centers
• Diagnostic Imaging Centers

7. Breast Imaging Devices Market Regional and Country Analysis

7.1. Global Breast Imaging Devices Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Breast Imaging Devices Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

• Siemens Healthcare
• GE Healthcare
• Dilon Technologies Inc.
• Hologic Inc
• Gamma Medica Inc
• Fujifilm Holdings Corporation
• SonoCine Inc
• Philips Healthcare
• Toshiba Corporation
• Aurora Imaging Technology Inc.
• Canon Inc.
• Dilon Technologies Inc
• Delphinus Medical Technologies
• Planmed Oy
• Micrima Limited
• CMR Naviscan Corporation
• SuperSonic Imagine
• Carestream Health
• Samsung Medison Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/rxq0qq

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900